INTRODUCTION
Antenatal corticosteroid therapy, given short term to accelerate fetal lung maturation, substantially improves the survival rate for preterm infants, with few known side effects [1] . In follow-up studies in humans [2] [3] [4] [5] [6] [7] [8] there have been few reports of adverse effects, but higher blood pressure in adulthood has been reported in several animal species after antenatal corticosteroid therapy, either throughout pregnancy [9] or after short-term exposure [10] . The aim of the present study was to determine the relationship between exposure to antenatal corticosteroids and blood pressure at 14 years of age in surviving preterm children.
METHODS
The 210 subjects of this study were all born in the Royal Women's Hospital, Melbourne. consecutive livebirths with birthweights of 1000-1500 g survived. All children were preterm births (gestational age range 24-36 completed weeks).
Extensive perinatal data had been collected, including the occurrence of maternal hypertension, with or without pre-eclampsia, in pregnancy. The mothers of some children had been given corticosteroids antenatally to accelerate fetal lung maturation. The method for determining who received corticosteroids was non-random ; some mothers had participated in a clinical trial [11] , but others were given corticosteroids at the discretion of the obstetrician. The corticosteroid was 24 mg of betamethasone, given in divided doses over 48 h [11] . No mother had more than one course of corticosteroids. Details of the early neonatal care of these cohorts have been described [12, 13] . No child received corticosteroids in the newborn period.
Surviving children were enrolled in a long-term followup programme, which was approved by the Research and Ethics Committees of the Royal Women's Hospital. They had been assessed several times earlier in childhood, and were assessed again at 14 years of age. Since all children were preterm, their age was corrected for prematurity, i.e. calculated from their expected date of birth if at term rather than their actual birth date. Blood pressure was measured with a standard mercury sphygmomanometer. Children were supine, after a short period of rest, and the cuff size was two-thirds of the upper arm length. The mean of three readings was recorded for both systolic and diastolic pressures. The paediatricians who assessed the children did so without any knowledge of perinatal details, including the child's exposure to antenatal corticosteroids. Blood pressure measurements were compared with published blood pressure data for children of the appropriate age and gender [14] to determine the proportion of subjects with values more than 2 S.D. above the mean. Height and weight were measured according to standard guidelines. Growth measurements at birth and at 14 years were converted to S.D. scores relative to the British Growth Reference [15] .
Data were edited and analysed using SPSS for Windows programs [16] . Dichotomous variables were compared by χ# analysis with correction for continuity. Differences in means were compared by t-test, and the mean difference and 95 % confidence intervals (CIs) were calculated, or by Mann-Whitney U test if the data were skewed. The relationships between blood pressure and potential confounding variables (gestational age, birthweight 1000 g or greater, birthweight S.D. score, maternal hypertension in pregnancy, gender, need for assisted ventilation, pneumothorax or other airleak, durations of assisted ventilation and oxygen therapy, and weight S.D. and height S.D. scores at 14 years of age) were analysed by stepwise multiple linear regression, and adjusted means and 95 % CIs for antenatal corticosteroid therapy were computed.
RESULTS
Blood pressure was measured at 14 years of age in 87.2 % (75\86) of subjects of birthweight 1000 g, and in 82.3 % (102\124) of subjects of birthweight 1000-1500 g. The mean age at blood pressure measurement was 14.2 (S.D. 0.3) years. The 177 children with blood pressure measurements at 14 years of age were not substantially different from the 33 children without blood pressure measurements with regard to potentially confounding perinatal and growth variables (Table 1) . For the children for whom blood pressure measurements were obtained at 14 years, most perinatal or growth variables were not significantly different between the 89 exposed to antenatal corticosteroids compared with the 88 not exposed to antenatal corticosteroids. However, children exposed to antenatal corticosteroids had a significantly lower rate of needing assisted ventilation, they required a shorter duration of oxygen therapy, and they had a significantly higher height S.D. score at 14 years of age ( Table 2 ). For subjects for whom blood pressure data was obtained at 14 years of age, the mean gestational age that corticosteroids had been given antenatally was 28.9 (S.D. 2.2) completed weeks.
Pubertal development was within normal limits for both groups, and there were no substantial differences between children exposed or not to antenatal corticosteroids. All but four of 45 girls and two of 44 girls in the respective groups had reached menarche, and all but three girls and one girl in the respective groups had stage 3 or more breast development. On univariate analysis, children exposed to antenatal corticosteroids had significantly higher systolic and diastolic blood pressures than those not exposed to corticosteroids (Table 3 ). The proportions of children with systolic or diastolic blood pressures more than 2 S.D. above the expected mean for age and gender were similar in the two groups (Table 3) .
Of the possible confounding variables in Table 2 , systolic blood pressure was significantly higher when the mother had hypertension in pregnancy (mean difference 4.7 mmHg ; 95 % CI 0.2-9.2), in males (mean difference 6.4 mmHg ; 95 % CI 2.9-10.0), if the child had an airleak in the newborn period (mean difference 6.1 mmHg ; 95 % CI 1.2-9.2), and with increasing weight S.D. score at 14 (mean difference 4.1 mmHg ; 95 % CI 2.6-5.6 per 1 S.D.). Diastolic blood pressure was significantly higher only with increasing weight S.D. score at 14 years (mean difference 1.9 mmHg ; 95 % CI 0.5-3.4 per 1 S.D.). The remaining variables were not significantly associated with blood pressure at 14 years. Of note, the birthweight S.D. score was not significantly related to either systolic (mean difference 0.3 mmHg ; 95 % CI k1.6 to 2.2 per 1 S.D.) or diastolic (mean difference 0.2 mmHg ; 95 % CI k1.2 to 1.5 per 1 S.D.) blood pressure. The mean Antenatal corticosteroids and blood pressure k0.15 (1.13) § k0.49 (1.02)R ¶ ‡ Seven mothers had hypertension throughout pregnancy, of whom six developed pre-eclampsia ; the remainder developed pre-eclampsia during pregnancy. § n l 1 without height data because non-ambulant due to cerebral palsy. R n l 3 without height data because non-ambulant due to cerebral palsy. ¶ Mean difference 0.34 (95 % CI 0.01-0.66).
difference between those who had received corticosteroids and those who had not remained significantly different after adjustment for the confounding variables for systolic blood pressure, but not for diastolic blood pressure (Table 3) . Only one child with high blood pressure at 14 years of age had a known pathological cause. This child had a blood pressure of 150\100 mmHg and was abusing anabolic steroids at 14 years of age, but was not exposed to antenatal corticosteroids. If this child's data were excluded, the differences in blood pressure between the two groups increased by approx. 0.4 mmHg, and the adjusted difference in diastolic blood pressure also became statistically significant (mean difference 2.9 mmHg ; 95 % CI 0.3-5.5). However, the difference between the proportions with systolic and diastolic blood pressures more than 2 S.D. above the mean remained statistically non-significant (systolic, χ# l 0 ; diastolic, χ# l 3.1).
Of the 177 children for whom blood pressure measurements were obtained, 12 (6.8 %) had cerebral palsy. Excluding these 12 children and adjusting for confounding variables, the children exposed to antenatal corticosteroids still had significantly elevated systolic blood pressure (mean difference 4.2 mmHg ; 95 % CI 0.5-7.9) but not diastolic blood pressure (mean difference 2.5 mmHg ; 95 % CI k0.3 to 5.3), unless the child abusing anabolic steroids was also excluded (mean difference 2.9 mmHg ; 95 % CI 0.2-5.7).
DISCUSSION
The fetal origin of chronic diseases in adulthood is an area of increasing interest in public health. Barker and colleagues [17] have reported associations between fetal growth retardation and adult diseases, including hypertension. A possible mechanism for producing hypertension is an increase in maternal glucocorticoid transfer to the fetus [18] . Benediktsson et al. [9] were able to induce higher systolic blood pressures in rats whose mothers were treated with dexamethasone throughout pregnancy. Moreover, Dodic et al. [10] reported an elevation in mean blood pressure in adult sheep whose mothers had been treated with short-term dexamethasone (48 h) in very early pregnancy (days 22-29), but not if the treatment was later in pregnancy (days 59-66 ; term 150 days). Antenatal corticosteroid therapy in the humans in our study was different from that in both of these animal models, with a single, short (48 h) course of treatment with betamethasone, and treatment was relatively later in pregnancy (mean 29 weeks ; term 40 weeks).
The pregnancy in preterm deliveries is clearly different from that in term deliveries, and the mechanisms related to the Barker hypothesis might or might not apply to the preterm infant. One of the major differences between preterm and term deliveries is the increasing use of antenatal corticosteroid therapy in preterm delivery. Antenatal corticosteroid therapy is known to improve neonatal survival in preterm infants, with few side effects [1] . Several groups have reported no major ill effects in childhood [2] [3] [4] [5] [6] [7] [8] . However, follow-up data of long-term effects, including on blood pressure, into adolescence and beyond are lacking.
Blood pressure data at 14 years of age were compared with the mean (S.D.) values for blood pressure from Rosner et al. [14] , rather than with data relative to height, age and gender, since we had four non-ambulant children in whom height could not be measured accurately. Moreover, although height S.D. score was related positively to blood pressure on univariate analysis in our study, the relationship with weight S.D. score was more important statistically, and the height S.D. score had no independent statistical significance.
As expected from the known advantages of antenatal corticosteroids, children exposed had less severe respiratory disease as newborns, as shown by a significantly lower proportion requiring assisted ventilation and significantly shorter durations of oxygen therapy. Sicker babies in the newborn period might have more interventions or complications that could perhaps damage their kidneys and predispose them to higher blood pressure. Although not recorded separately, few would have had umbilical catheters, since peripheral arterial and venous lines were preferred. Similarly, inotrope support was rare, and data were also not recorded. Of the measures of sickness in the newborn period, airleak was the only one that was significantly related to systolic blood pressure at 14 years. Adjusting for this and the other perinatal variables did not affect the significant relationship between higher blood pressure and antenatal corticosteroid exposure. No children had known renal disease at 14 years of age.
Of the potentially confounding variables other than airleak and growth at 14 years of age, systolic blood pressure was significantly higher in males, consistent with the known gender difference in the normative blood pressure data from the United States [14] . Systolic blood pressure was also higher in children whose mothers had hypertension in pregnancy ; this could reflect a genetic predisposition to higher blood pressure, or could be another example of programming of blood pressure in utero. Whatever the explanation, it is worthy of further study. Systolic blood pressure in childhood has been reported to be a better predictor of blood pressure in adulthood than is diastolic blood pressure [19] .
The size of the increase in systolic and diastolic blood pressures with antenatal corticosteroid exposure was small, and is of uncertain clinical significance at this age. Moreover, there was no difference between the groups in the small proportions of children who had blood pressures in the hypertensive range. However, we would not consider these children to have hypertension, unless repeated measurements were in this range [20] .
There are several implications of our study. First, although the study pertains to preterm children, the effects of the intrauterine environment may take many years to be manifested in preterm children, as in those born at term. Secondly, it is perhaps surprising that such a short exposure to corticosteroids antenatally might cause a small but statistically significant increase in blood pressure at 14 years of age. However, what is potentially more worrying is the contrast between the era in which the children in this study were born (the late 1970s to the early 1980s) and current practice in the 1990s. Today repeated doses of corticosteroids are often given antenatally, and large doses of corticosteroids are used postnatally to treat chronic lung disease in infants with similar gestational ages. None of the children in the present study were exposed to either repeated antenatal corticosteroids or postnatal corticosteroids. The effects of such therapies, including on blood pressure, must be evaluated, even if the survivors have to be followed for a long time after birth.
The children in the corticosteroid group did not have more hypertension at 14 years of age. However, the gap in blood pressure between those exposed and those not exposed to antenatal corticosteroid therapy may widen over time, and more children exposed to antenatal corticosteroid therapy might develop clinical hypertension as they grow older. Clearly their blood pressure should be re-evaluated in later life.
